1. Valdman S, Vander T, Bersudsky M, Ifergane G, Wirguin I. The Many Faces of the Guillain-Barre Syndrome. Neurology 2000;54(Suppl 3):A368. (Presented at the Annual meeting of the American Academy of Neurology, San Diego, Ca). 2. Vander T, Medvedovsky M, Hallevy H, Gozman G, Herishanu YO. Listeria monocytogenes meningitis in a patient with chronic hepatitis C, treated by interferon alfa and ribavirin. J Infect 2003; 46: 70-71. 3. Vander T, Medvedovsky M, Herishanu YO. Encephalopathy induced by oral acyclovir in a patient with normal renal function. J Infect 2003; 46: 286. 4. Vander T, Hallevy H, Ifergane G, Herishanu YO. Metformin induced encephalopathy without lactic acidosis. Diabet Med 2004; 21: 194-195. 5. Vander T, Medvedovsky M, Valdman S, Herishanu YO. Peripheral facial paralysis and meningitis caused by Rickettsia typhi infection. Scand J Infect Dis 2003; 35: 886- 887. 6. Vander T, Ifergane G. Transient post-ictal urinary retention: Presentation of 3 cases. Eur J Neurol 2004; 11: 207-208. 7. Vander T, Medvedovsky M, Duchanu L, Shelef I, Tomer A, Herishanu YO. Postmenopausal hormone replacement therapy and dural sinus thrombosis. Eur J Neurol 2004; 11: 569-71. 8. Vander T, Medvedovsky M, Herishanu YO. Epilepsia partialis continua possibly caused by cerebellar lesion. Cerebellum 2004; 3: 126-8. 9. Vander T, Hallevy C, Alsaed I, Valdman S, Ifergane G, Wirguin I. Positive 14-3-3 protein in the patient with Hashimoto's encephalopathy. J Neurol 2004;250: 1273-4.
ander T, Odi H, Bluvstein V, Ronen J, Catz A. Carbamazepine toxicity
following Oxybutynin and Dantrolene administration – A case report. Spinal cord
Rupture of Quadriceps Tendon in a Patient with Postanoxic Choreo-athetosis.
Disability and Rehabilitation 2005; 27: 597-599.
irguin I, Vander T, Brenner T, Abramsky O, Steiner I. Improvement of SSPE by
intrathecal infusion of alpha-IFN. Neurology 2005; 64: 402.
13. Benmoyal-Segal L, Vander T, Shifman S, Bryk B, Ebstein R, Marcus EL, Stessman J, Darvasi A, Herishanu Y, Friedman A, Soreq H. Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide-induced
Parkinson's disease. FASEB J. 2005 Jan 3.
14. Cohen AD, Vander T, Medvendovsky E, Biton A, Naimer S, Shalev R, Vardy DA Neuropathic scrotal pruritus: anogenital pruritus is a symptom of lumbosacral
radiculopathy. J Am Acad Dermatol. 2005;52:61-6
15. Hellden, A, Lycke , Vander T, Svensson Jan-Olof , Odar-Cederlof I, Stahle L. The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment.
Journal of Antimicrobial Chemotherapy. 2006;57(5):945-949
16. Medvedovsky M, Ifergane G, Wirguin I, Vander T, Dori A, Kipervasser S, Shifrin A, Vakhapova-Danicek V, Neufeld MY. Epilepsy Behav. 2006;8(2):429-33 17. Oksenberg A, Arons E, Nasser K, Vander T, Radwan H. REM-related obstructive sleep apnea: the effect of body position. JCSM 2010;6(4):343-348. RESEARCH
1. Open Label Clinical trial : Topiramate-drug of choice in partial epilepsy treatment. 2. Polymorphism of promoter of gene of AChE in chronically exposed to organophosphates parkinsonian patients of south Negev ( prof. H. Soreq and dr. A. Fridman).
LAVOISIER FUROSEMIDE 20 mg/2 ml, injectable solution (IM-IV) QUALITATIVE AND QUANTITATIVE COMPOSITION WARNINGS AND SPECIAL PRECAUTIONS FOR USE FUROSEMIDE. . 20.00 mg Warnings Accidental administration of furosemide may be conducive to hypovolemia associated with Sodium hydroxide …………. . s.q. pH 8.5 -9.5 Water for injectable preparations ……. . s.q. 2.00 ml In patie
K2/Spice Test PRECAUTIONS There is a possibility that technical or procedural error as well as other substances in certain foods and medicines may interfere with the test and cause incorrect results. Please refer to the “SPECIFICITY” section for 2. Do not use the product beyond the expiration date. lists of substances that will produce either positive results, or that do not interfere